Exenatide Research
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study
European Journal of Endocrinology·July 31, 2025
Endocrinology research group
Summary
Proof-of-principle study investigating exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia.
Study Details
Study Design
Randomized, placebo-controlled, double-blind, cross-over proof-of-principle study
Indication
Endogenous hyperinsulinemic hypoglycemia diagnosis
Intervention
Exenatide
Species
Human